Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of BRL 529.87 billion. The enterprise value is 628.20 billion.

Market Cap	529.87B
Enterprise Value	628.20B

Important Dates

The next confirmed earnings date is Wednesday, June 3, 2026.

Earnings Date	Jun 3, 2026
Ex-Dividend Date	Mar 26, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	86.85%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 21.71 and the forward PE ratio is 14.17.

PE Ratio	21.71
Forward PE	14.17
PS Ratio	2.82
PB Ratio	2.04
P/TBV Ratio	n/a
P/FCF Ratio	18.51
P/OCF Ratio	13.75
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.96, with an EV/FCF ratio of 21.95.

EV / Earnings	25.74
EV / Sales	3.56
EV / EBITDA	12.96
EV / EBIT	19.04
EV / FCF	21.95

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.57.

Current Ratio	2.54
Quick Ratio	1.55
Debt / Equity	0.57
Debt / EBITDA	2.88
Debt / FCF	5.19
Interest Coverage	9.30

Financial Efficiency

Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 7.98%.

Return on Equity (ROE)	9.39%
Return on Assets (ROA)	4.57%
Return on Invested Capital (ROIC)	7.98%
Return on Capital Employed (ROCE)	8.09%
Weighted Average Cost of Capital (WACC)	7.07%
Revenue Per Employee	1.98M
Profits Per Employee	256,925
Employee Count	95,000
Asset Turnover	0.39
Inventory Turnover	2.07

Taxes

In the past 12 months, Medtronic has paid 4.88 billion in taxes.

Income Tax	4.88B
Effective Tax Rate	16.59%

Stock Price Statistics

The stock price has decreased by -14.48% in the last 52 weeks. The beta is 0.76, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-14.48%
50-Day Moving Average	251.73
200-Day Moving Average	242.86
Relative Strength Index (RSI)	21.57
Average Volume (20 Days)	77

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.80

Income Statement

In the last 12 months, Medtronic had revenue of BRL 187.75 billion and earned 24.41 billion in profits. Earnings per share was 18.94.

Revenue	187.75B
Gross Profit	122.34B
Operating Income	35.08B
Pretax Income	29.43B
Net Income	24.41B
EBITDA	49.95B
EBIT	35.08B
Earnings Per Share (EPS)	18.94

Balance Sheet

The company has 44.36 billion in cash and 148.53 billion in debt, giving a net cash position of -103.41 billion.

Cash & Cash Equivalents	44.36B
Total Debt	148.53B
Net Cash	-103.41B
Net Cash Per Share	n/a
Equity (Book Value)	260.30B
Book Value Per Share	201.96
Working Capital	77.12B

Cash Flow

In the last 12 months, operating cash flow was 38.55 billion and capital expenditures -9.92 billion, giving a free cash flow of 28.62 billion.

Operating Cash Flow	38.55B
Capital Expenditures	-9.92B
Depreciation & Amortization	14.01B
Net Borrowing	-5.03B
Free Cash Flow	28.62B
FCF Per Share	n/a

Margins

Gross margin is 65.16%, with operating and profit margins of 18.68% and 13.00%.

Gross Margin	65.16%
Operating Margin	18.68%
Pretax Margin	15.67%
Profit Margin	13.00%
EBITDA Margin	26.60%
EBIT Margin	18.68%
FCF Margin	15.25%

Dividends & Yields

This stock pays an annual dividend of 5.48, which amounts to a dividend yield of 2.63%.

Dividend Per Share	5.48
Dividend Yield	2.63%
Dividend Growth (YoY)	-6.22%
Years of Dividend Growth	2
Payout Ratio	28.94%
Buyback Yield	0.83%
Shareholder Yield	3.46%
Earnings Yield	4.61%
FCF Yield	5.40%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.98 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	6